Treatment of anticonvulsant drug-induced bone disease (Q80041469)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

title

Treatment of anticonvulsant drug-induced bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Marc K Drezner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

volume

5 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

S41-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

The Effect of Anticonvulsant Therapy on Serum Levels of 25-Hydroxy-Vitamin D, Calcium, and Parathyroid Hormone

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Anticonvulsant therapy and vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Fracture risk is increased in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Evidence of osteomalacia in an outpatient group of adult epileptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Disturbance of Calcium Metabolism by Anticonvulsant Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Altered Calcium Metabolism in Epileptic Children on Anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Antiepileptic Drugs and Vitamin D Supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Effect of increasing doses of phenytoin on the plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Antiepileptic drug-induced bone loss in young male patients who have seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Effect of carbamazepine and valproate on bone mineral density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Phenobarbital-induced alterations in vitamin D metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Absorption and Biotransformation of Cholecalciferol in Drug-Induced Osteomalacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Renal toxicity induced by valproic acid (Depakene).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Influence of Diphenylhydantoin and Phenobarbital on Intestinal Calcium Transport in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Phenytoin inhibition of parathyroid hormone induced bone resorption in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3, 5 cyclic monophosphate production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Calcium balance in drug-induced osteomalacia: Response to vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEBEH.2003.11.028

10.1016/J.YEBEH.2003.11.028

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15123011 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference